Connect your AI

Aclaris Therapeutics ACRS Earnings yield

Earnings yield at other companies

IncyteINCY

7.6%+7.5pp

Corvus PharmaceuticalsCRVS

-3.6%-1.6pp

Upstream Bio, Inc.UPB

-32%+15.6pp

Avalo TherapeuticsAVTX

-24.9%-110pp

Shattuck Labs, Inc.STTK

-10.8%-5.2pp

Apogee Therapeutics, Inc.APGE

-4.4%-1.5pp

Other financials

Income statement

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

net income/market cap=-15.3%

Based on trailing twelve months.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aclaris Therapeutics's earnings yield?: Aclaris Therapeutics (ACRS) reported earnings yield of -15.3% in Q1 2026.
How has Aclaris Therapeutics's earnings yield changed year-over-year?: Aclaris Therapeutics's earnings yield increased by 80.5% year-over-year, from -78.7% to -15.3%.
What is the long-term trend for Aclaris Therapeutics's earnings yield?: Over 5 years (2020 to 2025), Aclaris Therapeutics's earnings yield has grown at a 9.1% compound annual growth rate (CAGR), from -12.9% to -19.9%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.